{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:52:13Z","timestamp":1793847133782,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02726-0","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T09:30:42Z","timestamp":1745227842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antitumor potential of ivermectin against T-cell lymphoma-bearing hosts"],"prefix":"10.1007","volume":"42","author":[{"given":"Alok","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"2726_CR1","doi-asserted-by":"publisher","first-page":"115849","DOI":"10.1016\/j.jep.2022.115849","volume":"302","author":"S Kumar","year":"2023","unstructured":"Kumar S, et al. Moringa oleifera L. leaf extract induces cell cycle arrest and mitochondrial apoptosis in Dalton\u2019s Lymphoma: An in vitro and in vivo study. J Ethnopharmacol. 2023;302:115849. https:\/\/doi.org\/10.1016\/j.jep.2022.115849.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"2726_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2726_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/medsci9010005","volume":"9","author":"KC Thandra","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of non-hodgkin\u2019s lymphoma. Med Sci Basel Switz. 2021;9(1):5. https:\/\/doi.org\/10.3390\/medsci9010005.","journal-title":"Med Sci Basel Switz"},{"key":"2726_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106772","volume":"113","author":"RK Singh","year":"2022","unstructured":"Singh RK, et al. Evidence that PKC\u03b1 inhibition in Dalton\u2019s Lymphoma cells augments cell cycle arrest and mitochondrial-dependent apoptosis. Leuk Res. 2022;113: 106772. https:\/\/doi.org\/10.1016\/j.leukres.2021.106772.","journal-title":"Leuk Res"},{"issue":"1","key":"2726_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-017-0436-9","volume":"10","author":"GJ Yoshida","year":"2017","unstructured":"Yoshida GJ. Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment. J Hematol Oncol J Hematol Oncol. 2017;10(1):67. https:\/\/doi.org\/10.1186\/s13045-017-0436-9.","journal-title":"J Hematol Oncol J Hematol Oncol"},{"issue":"1","key":"2726_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drudis.2015.09.017","volume":"21","author":"R W\u00fcrth","year":"2016","unstructured":"W\u00fcrth R, Thellung S, Bajetto A, Mazzanti M, Florio T, Barbieri F. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds. Drug Discov Today. 2016;21(1):190\u20139. https:\/\/doi.org\/10.1016\/j.drudis.2015.09.017.","journal-title":"Drug Discov Today"},{"key":"2726_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105207","volume":"163","author":"M Tang","year":"2021","unstructured":"Tang M, et al. Ivermectin, a potential anticancer drug derived from an antiparasitic drug. Pharmacol Res. 2021;163: 105207. https:\/\/doi.org\/10.1016\/j.phrs.2020.105207.","journal-title":"Pharmacol Res"},{"issue":"4613","key":"2726_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.6308762","volume":"221","author":"WC Campbell","year":"1983","unstructured":"Campbell WC, Fisher MH, Stapley EO, Albers-Sch\u00f6nberg G, Jacob TA. Ivermectin: a potent new antiparasitic agent. Science. 1983;221(4613):823\u20138. https:\/\/doi.org\/10.1126\/science.6308762.","journal-title":"Science"},{"issue":"10","key":"2726_CR9","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1021\/jm00184a014","volume":"23","author":"JC Chabala","year":"1980","unstructured":"Chabala JC, et al. Ivermectin, a new broad-spectrum antiparasitic agent. J Med Chem. 1980;23(10):1134\u20136. https:\/\/doi.org\/10.1021\/jm00184a014.","journal-title":"J Med Chem"},{"issue":"2","key":"2726_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2249.1993.tb03452.x","volume":"94","author":"FL Njoo","year":"1993","unstructured":"Njoo FL, Hack CE, Oosting J, Stilma JS, Kijlstra A. Neutrophil activation in ivermectin-treated onchocerciasis patients. Clin Exp Immunol. 1993;94(2):330\u20133. https:\/\/doi.org\/10.1111\/j.1365-2249.1993.tb03452.x.","journal-title":"Clin Exp Immunol"},{"issue":"21","key":"2726_CR11","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1001\/jama.1988.03720210040026","volume":"259","author":"V Kumaraswami","year":"1988","unstructured":"Kumaraswami V, et al. Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions. JAMA. 1988;259(21):3150\u20133.","journal-title":"JAMA"},{"issue":"5","key":"2726_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4269\/ajtmh.1996.55.477","volume":"55","author":"H Marti","year":"1996","unstructured":"Marti H, et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg. 1996;55(5):477\u201381. https:\/\/doi.org\/10.4269\/ajtmh.1996.55.477.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"2726_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/0972-9062.213454","volume":"49","author":"UK Udensi","year":"2012","unstructured":"Udensi UK, Fagbenro-Beyioku AF. Effect of ivermectin on Trypanosoma brucei brucei in experimentally infected mice. J Vector Borne Dis. 2012;49(3):143\u201350.","journal-title":"J Vector Borne Dis"},{"issue":"1","key":"2726_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/vbz.2009.0030","volume":"11","author":"HA Hanafi","year":"2011","unstructured":"Hanafi HA, et al. Effects of ivermectin on blood-feeding Phlebotomus papatasi, and the promastigote stage of Leishmania major. Vector Borne Zoonotic Dis Larchmt N. 2011;11(1):43\u201352. https:\/\/doi.org\/10.1089\/vbz.2009.0030.","journal-title":"Vector Borne Zoonotic Dis Larchmt N"},{"issue":"3","key":"2726_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3347\/kjp.2013.51.3.297","volume":"51","author":"MMA Basyoni","year":"2013","unstructured":"Basyoni MMA, El-Sabaa A-AA. Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice. Korean J Parasitol. 2013;51(3):297\u2013304. https:\/\/doi.org\/10.3347\/kjp.2013.51.3.297.","journal-title":"Korean J Parasitol"},{"issue":"3","key":"2726_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/cid\/ciu797","volume":"60","author":"AL Ou\u00e9draogo","year":"2015","unstructured":"Ou\u00e9draogo AL, et al. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;60(3):357\u201365. https:\/\/doi.org\/10.1093\/cid\/ciu797.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"25","key":"2726_CR17","doi-asserted-by":"publisher","first-page":"13949","DOI":"10.1073\/pnas.240464697","volume":"97","author":"NS Kane","year":"2000","unstructured":"Kane NS, et al. Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. Proc Natl Acad Sci U S A. 2000;97(25):13949\u201354. https:\/\/doi.org\/10.1073\/pnas.240464697.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2726_CR18","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1073\/pnas.76.4.2062","volume":"76","author":"LC Fritz","year":"1979","unstructured":"Fritz LC, Wang CC, Gorio A. Avermectin B1a irreversibly blocks postsynaptic potentials at the lobster neuromuscular junction by reducing muscle membrane resistance. Proc Natl Acad Sci U S A. 1979;76(4):2062\u20136. https:\/\/doi.org\/10.1073\/pnas.76.4.2062.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2726_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.717529","volume":"12","author":"S Zhou","year":"2021","unstructured":"Zhou S, et al. Ivermectin has new application in inhibiting colorectal cancer cell growth. Front Pharmacol. 2021;12: 717529. https:\/\/doi.org\/10.3389\/fphar.2021.717529.","journal-title":"Front Pharmacol"},{"issue":"35","key":"2726_CR20","doi-asserted-by":"publisher","first-page":"E7301","DOI":"10.1073\/pnas.1705441114","volume":"114","author":"M Kodama","year":"2017","unstructured":"Kodama M, et al. In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer. Proc Natl Acad Sci U S A. 2017;114(35):E7301\u201310. https:\/\/doi.org\/10.1073\/pnas.1705441114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2726_CR21","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1158\/1535-7163.MCT-14-0980-T","volume":"14","author":"Y-J Kwon","year":"2015","unstructured":"Kwon Y-J, et al. Selective inhibition of SIN3 corepressor with avermectins as a novel therapeutic strategy in triple-negative breast cancer. Mol Cancer Ther. 2015;14(8):1824\u201336. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0980-T.","journal-title":"Mol Cancer Ther"},{"issue":"18","key":"2726_CR22","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1182\/blood-2010-01-262675","volume":"116","author":"S Sharmeen","year":"2010","unstructured":"Sharmeen S, et al. The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. Blood. 2010;116(18):3593\u2013603. https:\/\/doi.org\/10.1182\/blood-2010-01-262675.","journal-title":"Blood"},{"issue":"1","key":"2726_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13046-019-1251-7","volume":"38","author":"L Jiang","year":"2019","unstructured":"Jiang L, Wang P, Sun Y-J, Wu Y-J. Ivermectin reverses the drug resistance in cancer cells through EGFR\/ERK\/Akt\/NF-\u03baB pathway. J Exp Clin Cancer Res CR. 2019;38(1):265. https:\/\/doi.org\/10.1186\/s13046-019-1251-7.","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"6","key":"2726_CR24","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00280-020-04041-z","volume":"85","author":"M Juarez","year":"2020","unstructured":"Juarez M, Schcolnik-Cabrera A, Dominguez-Gomez G, Chavez-Blanco A, Diaz-Chavez J, Duenas-Gonzalez A. Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Cancer Chemother Pharmacol. 2020;85(6):1153\u201363. https:\/\/doi.org\/10.1007\/s00280-020-04041-z.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2726_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/DDDT.S237393","volume":"14","author":"J Liu","year":"2020","unstructured":"Liu J, Zhang K, Cheng L, Zhu H, Xu T. Progress in understanding the molecular mechanisms underlying the antitumour effects of ivermectin. Drug Des Devel Ther. 2020;14:285\u201396. https:\/\/doi.org\/10.2147\/DDDT.S237393.","journal-title":"Drug Des Devel Ther"},{"key":"2726_CR26","doi-asserted-by":"publisher","DOI":"10.17352\/2455-8591.000011","author":"K Raj Kumar","year":"2017","unstructured":"Raj Kumar K. Dalton\u2019s lymphoma as a murine model for understanding the progression and development of T-cell lymphoma and its role in drug discovery. Int J Immunother Cancer Res. 2017. https:\/\/doi.org\/10.17352\/2455-8591.000011.","journal-title":"Int J Immunother Cancer Res"},{"key":"2726_CR27","doi-asserted-by":"publisher","first-page":"136473","DOI":"10.1016\/j.molstruc.2023.136473","volume":"1294","author":"S Chandra","year":"2023","unstructured":"Chandra S, Jaiswal S, Shukla A, Singh AK, Garai S, Bharti A, Bharty MK. Solvent-dependent crystallization and anti-cancer activities based on Ni (II) and Co (II) complexes of 1-picolinoyl-4-phenyl-3-thiosemicarbazide: Synthesis, crystal structure, and photoluminescence study. J Mol Struct. 2023;1294:136473.","journal-title":"J Mol Struct"},{"key":"2726_CR28","doi-asserted-by":"publisher","first-page":"114060","DOI":"10.1016\/j.jep.2021.114060","volume":"274","author":"RK Singh","year":"2021","unstructured":"Singh RK, Verma PK, Kumar A, Kumar S, Acharya A. Achyranthes aspera L. leaf extract induced anticancer effects on Dalton\u2019s Lymphoma via regulation of PKC\u03b1 signaling pathway and mitochondrial apoptosis. J Ethnopharmacol. 2021;274:114060.","journal-title":"J Ethnopharmacol"},{"issue":"1\u20132","key":"2726_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1\u20132):55\u201363.","journal-title":"J Immunol Methods"},{"key":"2726_CR30","doi-asserted-by":"publisher","first-page":"131547","DOI":"10.1016\/j.molstruc.2021.131547","volume":"1249","author":"MK Gond","year":"2022","unstructured":"Gond MK, Shukla A, Pandey SK, Bharty MK, Maiti B, Acharya A, Butcher RJ. Mn (II) catalyzed synthesis of 5 (4-hydroxyphenyl)-2-(N-phenylamino)-1, 3, 4-oxadiazole: crystal structure, DFT, molecular docking, Hirshfeld surface analysis, and in vitro anticancer activity on DL cells. J Mol Struct. 2022;1249:131547.","journal-title":"J Mol Struct"},{"key":"2726_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s12013-023-01193-6","volume":"82","author":"N Kumar","year":"2024","unstructured":"Kumar N, Shukla A, Kumar S, Ulasov I, Singh RK, Kumar S, Acharya A. FNC (4\u2032-azido-2\u2032-deoxy-2\u2032-fluoro (arbino) cytidine) as an effective therapeutic agent for NHL: ROS generation, cell cycle arrest, and mitochondrial-mediated apoptosis. Cell Biochem Biophys. 2024;82:623.","journal-title":"Cell Biochem Biophys"},{"issue":"4","key":"2726_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/md16040125","volume":"16","author":"ZZ Wu","year":"2018","unstructured":"Wu ZZ, Ding GF, Huang FF, Yang ZS, Yu FM, Tang YP, Chen R. Anticancer activity of anthopleura anjunae oligopeptides in prostate cancer DU-145 cells. Mar Drugs. 2018;16(4):125.","journal-title":"Mar Drugs"},{"issue":"1","key":"2726_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40199-022-00439-7","volume":"30","author":"PK Verma","year":"2022","unstructured":"Verma PK, Singh RK, Kumar S, Shukla A, Kumar S, Gond MK, Acharya A. Cobalt (III) complex exerts anti-cancer effects on T cell lymphoma through induction of cell cycle arrest and promotion of apoptosis. DARU J Pharm Sci. 2022;30(1):127\u201338.","journal-title":"DARU J Pharm Sci"},{"issue":"1","key":"2726_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12672-023-00829-6","volume":"15","author":"N Kumar","year":"2024","unstructured":"Kumar N, Kumar S, Shukla A, Kumar S, Singh RK, Ulasov I, Acharya A. Mitochondrial-mediated apoptosis as a therapeutic target for FNC (2\u2032-deoxy-2\u2032-b-fluoro-4\u2032-azidocytidine)-induced inhibition of Dalton\u2019s lymphoma growth and proliferation. Discover Oncol. 2024;15(1):16.","journal-title":"Discover Oncol"},{"issue":"1","key":"2726_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/jcb.27420","volume":"120","author":"D Song","year":"2019","unstructured":"Song D, Liang H, Qu B, Li Y, Liu J, Zhang Y, Gao A. Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo. J Cellular Biochem. 2019;120(1):622\u201333.","journal-title":"J Cellular Biochem"},{"issue":"6","key":"2726_CR36","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1091\/mbc.12.6.1569","volume":"12","author":"RG Deschesnes","year":"2001","unstructured":"Deschesnes RG, Huot J, Valerie K, Landry J. Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol Biol Cell. 2001;12(6):1569\u201382.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"2726_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","volume":"17","author":"T Otto","year":"2017","unstructured":"Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17(2):93\u2013115.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2726_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrd2907","volume":"8","author":"S Lapenna","year":"2009","unstructured":"Lapenna S, Giordano A. Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov. 2009;8(7):547\u201366.","journal-title":"Nat Rev Drug Discov"},{"issue":"2\u20133","key":"2726_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0300-9084(02)01369-X","volume":"84","author":"C Fleury","year":"2002","unstructured":"Fleury C, Mignotte B, Vayssi\u00e8re JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84(2\u20133):131\u201341.","journal-title":"Biochimie"},{"key":"2726_CR40","doi-asserted-by":"publisher","first-page":"13829","DOI":"10.1021\/acsomega.4c06972","volume":"10","author":"S Gupta","year":"2025","unstructured":"Gupta S, Shukla A, Pandey SK, Jha S, Zewde B, Acharya A, Bharty MK. Piperazine-Based Co (III), Ni (II), Cu (II), and Zn (II) Carbodithioate Complexes as Potential Anticancer Agent. ACS Omega. 2025;10:13829\u201338.","journal-title":"ACS Omega"},{"issue":"3","key":"2726_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbrc.2016.10.064","volume":"480","author":"Y Liu","year":"2016","unstructured":"Liu Y, Fang S, Sun Q, Liu B. Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress. Biochem Biophys Res Commun. 2016;480(3):415\u201321.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2726_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00280-023-04589-6","volume":"93","author":"MY Li","year":"2024","unstructured":"Li MY, Zhang J, Lu X, Zhou D, Deng XF, Liu QX, Zheng H. Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells. Cancer Chemother Pharmacol. 2024;93(1):41\u201354.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"15","key":"2726_CR43","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1158\/0008-5472.CAN-15-2887","volume":"76","author":"Q Dou","year":"2016","unstructured":"Dou Q, Chen HN, Wang K, Yuan K, Lei Y, Li K, Huang C. Ivermectin induces cytostatic autophagy by blocking the PAK1\/Akt axis in breast cancer. Cancer Res. 2016;76(15):4457\u201369.","journal-title":"Cancer Res"},{"key":"2726_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0378-4274(99)00252-0","volume":"112","author":"KM Debatin","year":"2000","unstructured":"Debatin KM. Activation of apoptosis pathways by anticancer treatment. Toxicol Lett. 2000;112:41\u20138.","journal-title":"Toxicol Lett"},{"issue":"2","key":"2726_CR45","doi-asserted-by":"publisher","first-page":"e12543","DOI":"10.1111\/cpr.12543","volume":"52","author":"P Zhang","year":"2019","unstructured":"Zhang P, Zhang Y, Liu K, Liu B, Xu W, Gao J, Tao L. Ivermectin induces cell cycle arrest and apoptosis of HeLa cells via mitochondrial pathway. Cell Prolif. 2019;52(2):e12543.","journal-title":"Cell Prolif"},{"issue":"10","key":"2726_CR46","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.7150\/ijms.76623","volume":"19","author":"CL Tung","year":"2022","unstructured":"Tung CL, Chao WY, Li YZ, Shen CH, Zhao PW, Chen SH, Lee YR. Ivermectin induces cell cycle arrest and caspase-dependent apoptosis in human urothelial carcinoma cells. Int J Med Sci. 2022;19(10):1567.","journal-title":"Int J Med Sci"},{"key":"2726_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-019-2026-2","volume":"15","author":"H Diao","year":"2019","unstructured":"Diao H, Cheng N, Zhao Y, Xu H, Dong H, Thamm DH, Lin D. Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling. BMC Veterinary Res. 2019;15:1\u201310.","journal-title":"BMC Veterinary Res"},{"key":"2726_CR48","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00204-012-0906-3","volume":"86","author":"JM Mat\u00e9s","year":"2012","unstructured":"Mat\u00e9s JM, Segura JA, Alonso FJ, M\u00e1rquez J. Oxidative stress in apoptosis and cancer: an update. Arch Toxicol. 2012;86:1649\u201365.","journal-title":"Arch Toxicol"},{"issue":"3","key":"2726_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0928-4680(00)00053-5","volume":"7","author":"K Kannan","year":"2000","unstructured":"Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology. 2000;7(3):153\u201363.","journal-title":"Pathophysiology"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02726-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02726-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02726-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T01:57:37Z","timestamp":1746151057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02726-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["2726"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02726-0","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"All experiments adhered to protocols approved by the Animal Ethics Committee of the Indian Institute of Technology (BHU), with the study receiving approval under IAEC Approval Number: IIT (BHU) IAEC\/2024\/II\/001.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"169"}}